Trials / Unknown
UnknownNCT02848807
Chemotherapy-related Toxicity, Nutritional Status and Quality of Life
Chemotherapy-related Toxicity, Nutritional Status and Quality of Life in Precachectic Oncologic Patients With or Without High Protein Nutritional Support. A Prospective, Randomized Study
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 100 (estimated)
- Sponsor
- University Clinical Centre, Gdansk · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Determine whether nutritional support with high protein ONS in adult oncologic patients in the first step of cancer cachexia - asymptomatic precachexia, influence on the toxicity of systemic therapy.
Detailed description
Other endpoints: * to determine whether high protein ONS influence on the nutritional status * to determine whether high protein ONS influence on the quality of life * to determine whether high protein ONS influence on the performance status * to determine high protein ONS tolerability / ONS intake compliance
Conditions
- Toxicity Due to Chemotherapy
- Cancer Cachexia
- Metastatic Colorectal Cancer
- Quality of Life
- Dietary Modification
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | NUTRIDRINK Compact Protein | high-energy, high-protein, oral liquid nutritional supplement; dosage: 2x125 ml per day, 7 days per week for 12 weeks (3 months) |
Timeline
- Start date
- 2014-09-01
- Primary completion
- 2016-12-01
- Completion
- 2016-12-01
- First posted
- 2016-07-29
- Last updated
- 2016-07-29
Locations
1 site across 1 country: Poland
Source: ClinicalTrials.gov record NCT02848807. Inclusion in this directory is not an endorsement.